| Application no. and date | 11157965.2 (espacenet) (Federated) (European Patent Register), 20070614 | | Patent/reg. no. and date | DK/EP 2364691, 20130424 | | Publication date | 20110914 | | Priority no. and date | US 814484 P, 20060616 | | EP pub. no. and date |
EP 2364691 20110914 | | Effective date | | | Applicant/owner | REGENERON PHARMACEUTICALS, INC., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | P288DKEP | | Inventor | DIX, Daniel, 55 Memory Trail
La Grangeville, NY 12540, US,
FURFINE, Eric, 315 Harrington Avenue
Concord, MA 01742, US,
GRAHAM, Kenneth, S., 218 Robbout Road
Pleasant Valley, NY 12569, US,
FRYE, Kelly, 29 N. Ridge Road
Pomona, NY 10970, US | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) | | Title | VEGF antagonist-formuleringer, der kan anvendes til intravitreal administration | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
